MHRA confirms that people should continue to receive the COVID-19 vaccine AstraZeneca

Following a rigorous scientific review of all the available data, the MHRA said that the available evidence does not suggest that blood clots in veins (venous thromboembolism) are caused by COVID-19 Vaccine AstraZeneca.

The MHRA’s advice remains that the benefits of the vaccines against COVID-19 continue to outweigh any risks and that the public should continue to get their vaccine when invited to do so.

Further information can be found in the full statement on the MHRA website.